Abdelaziz HE, El-Guendy N, Radwan EM, Sharawi SK, El-Houseini ME, Abdel-Wahab AA (2022) Possible use of miR-223–3p as a prognostic marker in transarterial chemoembolization treatment of hepatocellular carcinoma patients. Asian Pac J Cancer Prevention: APJCP 23(12):4125–35

Article  CAS  Google Scholar 

Adamska A, Ferro R, Lattanzio R, Capone E, Domenichini A, Damiani V et al (2019) ABCC3 is a novel target for the treatment of pancreatic cancer. Adv Biol Regul 73:100634

Article  PubMed  CAS  Google Scholar 

Adeshakin FO, Adeshakin AO, Afolabi LO, Yan D, Zhang G, Wan X (2021) Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming. Front Oncol 11:626577

Article  PubMed  PubMed Central  CAS  Google Scholar 

Afonso-Grunz F, Müller S (2015) Principles of miRNA–mRNA interactions: beyond sequence complementarity. Cell Mol Life Sci 72(16):3127–3141

Article  PubMed  PubMed Central  CAS  Google Scholar 

Afrashteh Nour M, Hajiasgharzadeh K, Kheradmand F, Asadzadeh Z, Bolandi N, Baradaran B (2021) Nicotinic acetylcholine receptors in chemotherapeutic drugs resistance: an emerging targeting candidate. Life Sci 278:119557

Article  PubMed  CAS  Google Scholar 

Ahmadi D, Zarei M, Rahimi M, Khazaie M, Asemi Z, Mir SM et al (2020) Preparation and in-vitro evaluation of pH-responsive cationic cyclodextrin coated magnetic nanoparticles for delivery of methotrexate to the Saos-2 bone cancer cells. J Drug Deliv Sci Technol 57:101584

Article  CAS  Google Scholar 

Algorashi I, Goldvaser H, Ribnikar D, Cescon DW, Amir E (2018) Evolution in sites of recurrence over time in breast cancer patients treated with adjuvant endocrine therapy. Cancer Treat Rev 70:138–143

Article  PubMed  Google Scholar 

Alizadeh-Fanalou S, Hosseinkhani S, Nazarizadeh A, Ezzati-Mobaser S, Hesari Z, Aziminezhadan P et al (2021) MiR-613 promotes cell death in breast cancer cells by downregulation of nicotinamide phosphoribosyltransferase and reduction of NAD. DNA Cell Biol 40(7):1026–1036

Article  PubMed  CAS  Google Scholar 

Alla V, Kowtharapu BS, Engelmann D, Emmrich S, Schmitz U, Steder M et al (2012) E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry. Cell Cycle (Georgetown, Tex) 11(16):3067–3078

Article  PubMed  PubMed Central  CAS  Google Scholar 

Al-Momany B, Hammad H, Ahram M (2021) Dihydrotestosterone induces chemo-resistance of triple-negative breast MDA-MB-231 cancer cells towards doxorubicin independent of ABCG2 and miR-328-3p. Curr Mol Pharmacol 14(5):860–870

Article  PubMed  CAS  Google Scholar 

Alsanosi SMM, Skiffington C, Padmanabhan S (2014) Chapter 17 - pharmacokinetic pharmacogenomics. In: Padmanabhan S (ed) Handbook of Pharmacogenomics and Stratified Medicine. Academic Press, San Diego, pp 341–364

Chapter  Google Scholar 

Alvarez M, Paull K, Monks A, Hose C, Lee JS, Weinstein J et al (1995) Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. J Clin Invest 95(5):2205–2214

Article  PubMed  PubMed Central  CAS  Google Scholar 

Amawi H, Sim HM, Tiwari AK, Ambudkar SV, Shukla S (2019) ABC Transporter-mediated multidrug-resistant cancer. Adv Exp Med Biol 1141:549–580

Article  PubMed  CAS  Google Scholar 

Asaduzzaman M, Constantinou S, Min H, Gallon J, Lin ML, Singh P et al (2017) Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer. Breast Cancer Res Treat 163(3):461–474

Article  PubMed  PubMed Central  CAS  Google Scholar 

Asaduzzaman M, Constantinou S, Min H, Gallon J, Lin ML, Singh P et al (2018) Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer. Breast Cancer Res Treat 167(2):605–606

Article  PubMed  PubMed Central  Google Scholar 

Bao L, Hazari S, Mehra S, Kaushal D, Moroz K, Dash S (2012) Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. Am J Pathol 180(6):2490–2503

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bao J, Xu Y, Wang Q, Zhang J, Li Z, Li D et al (2017) miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2. Biomed Pharmacother=Biomed Pharmacother 92:1030–7

Article  PubMed  CAS  Google Scholar 

Bates SE (2003) Chapter 18 - solving the problem of multidrug resistance: ABC transporters in clinical oncology. In: Holland IB, Cole SPC, Kuchler K, Higgins CF (eds) ABC Proteins. Academic Press, London, pp 359–391

Chapter  Google Scholar 

Begicevic R-R, Falasca M (2017) ABC transporters in cancer stem cells: beyond chemoresistance. Int J Mol Sci 18(11):2362

Article  PubMed  PubMed Central  Google Scholar 

Beis K (2015) Structural basis for the mechanism of ABC transporters. Biochem Soc Trans 43(5):889–893

Article  PubMed  CAS  Google Scholar 

Bhattacharjee M, Ghosh A, Das S, Sarker S, Bhattacharya S, Das A et al (2024) Systemic codelivery of thymoquinone and doxorubicin by targeted mesoporous silica nanoparticle sensitizes doxorubicin-resistant breast cancer by interfering between the MDR1/P-gp and miR 298 crosstalk. ACS Biomater Sci Eng 10(10):6314–6331

Article  PubMed  CAS  Google Scholar 

Bi DP, Yin CH, Zhang XY, Yang NN, Xu JY (2016) MiR-183 functions as an oncogene by targeting ABCA1 in colon cancer. Oncol Rep 35(5):2873–2879

Article  PubMed  CAS  Google Scholar 

Blair BG, Larson CA, Adams PL, Abada PB, Safaei R, Howell SB (2010) Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells. Mol Pharmacol 77(6):912–921

Article  PubMed  PubMed Central  CAS  Google Scholar 

Borst P, Evers R, Kool M, Wijnholds J (2000) A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 92(16):1295–1302

Article  PubMed  CAS  Google Scholar 

Bourguignon LY, Spevak CC, Wong G, Xia W, Gilad E (2009) Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem 284(39):26533–26546

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bouvy C, Wannez A, Laloy J, Chatelain C, Dogné JM (2017) Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo. Leuk Res 62:70–76

Article  PubMed  CAS  Google Scholar 

Boyerinas B, Park SM, Murmann AE, Gwin K, Montag AG, Zillhardt M et al (2012) Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1. Int J Cancer 130(8):1787–1797

Article  PubMed  CAS  Google Scholar 

Bruhn O, Lindsay M, Wiebel F, Kaehler M, Nagel I, Böhm R et al (2020) Alternative polyadenylation of ABC transporters of the C-Family (ABCC1, ABCC2, ABCC3) and implications on posttranscriptional micro-RNA regulation. Mol Pharmacol 97(2):112–122

Article  PubMed  CAS  Google Scholar 

Bugde P, Biswas R, Merien F, Lu J, Liu DX, Chen M et al (2017) The therapeutic potential of targeting ABC transporters to combat multi-drug resistance. Expert Opin Ther Targets 21(5):511–530

Article  PubMed  Google Scholar 

Bukowski K, Kciuk M, Kontek R (2020) Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci 21(9):3233

Article  PubMed  PubMed Central  CAS